...
首页> 外文期刊>Annals of geriatric medicine and research. >An Elderly Patient With Prostate Cancer and Colon Cancer 10 Years After a Diagnosis of Medullary Thyroid Carcinoma
【24h】

An Elderly Patient With Prostate Cancer and Colon Cancer 10 Years After a Diagnosis of Medullary Thyroid Carcinoma

机译:髓样甲状腺癌诊断十年后的老年前列腺癌和结肠癌患者

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Medullary thyroid carcinomas (MTC) are rare tumors that account for approximately 5-10% of all thyroid malignancy in the West. The reported incidence of MTC is less than 5% in Korea. Its prognosis is relatively good with a 15-year survival rate of 64-84%. The incidence of thyroid cancer has been increasing rapidly worldwide and the overall survival of patients with thyroid cancer is excellent. The occurrence of second primary malignancy (SPM) among survivors of thyroid cancer is a concern, together with life expectancy. Recent studies reported a 6-45% increase in the risk of developing SPM after the diagnosis thyroid cancer. We reported a patient with prostate and colon cancer that were diagnosed 10 years after the diagnosis of medullary thyroid carcinoma.
机译:甲状腺髓样癌(MTC)是罕见的肿瘤,约占西方所有甲状腺恶性肿瘤的5-10%。据报道,韩国的MTC发生率低于5%。其预后相对较好,15年生存率为64-84%。在世界范围内,甲状腺癌的发病率一直在迅速增加,并且甲状腺癌患者的总体存活率非常好。甲状腺癌幸存者中第二原发性恶性肿瘤(SPM)的发生以及预期寿命令人担忧。最近的研究报道,在诊断出甲状腺癌后,发生SPM的风险增加了6-45%。我们报告了一名甲状腺髓样癌诊断为10年后被诊断为前列腺癌和结肠癌的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号